Vaccinology update 2004;Vaccinologie

Revue Medicale Suisse

Volumn 1, Issue 1, 2005, Pages 79-82

  Siegrist, Claire Anne ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANATOXAL; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; DT VAX; ENFANTS; ENGERIX; FSME IMMUN; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B VACCINE; MERCURY; MERIEUX; PNEUMOCOCCUS VACCINE; POLIORIX; RABIES VACCINE; RECOMBINANT HEPATITIS B VACCINE; REVAXIS; RUBEATEN; UNCLASSIFIED DRUG; VACCINE; VARICELLA ZOSTER VACCINE;

CHICKENPOX; DOSE RESPONSE; HEALTH CARE ORGANIZATION; HEPATITIS B; HUMAN; IMMUNIZATION; INTERNET; MEASLES; PHYSICIAN; REVIEW; RISK FACTOR; RUBELLA; STREPTOCOCCUS INFECTION; SWITZERLAND; VACCINATION; ADOLESCENT; ADULT; ARTICLE; CHILD; INFANT; PRESCHOOL CHILD; STANDARD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION; INFANT; VACCINES;

EID: 21844454765     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Supplément VIII (Etat Janvier 2004), Classeur «Maladies Infectieuses - Diagnostic et Prévention». http://www.bag.admin.ch/ infekt/publ/supplementa/f/suppl8_ impfpl.pdf
2. Ceyhan M, Kanra G, Erdem G, Kanra B. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age. Vaccine 2001;19:4473-8.
3. Gans H, Yasukawa L, Rinki M, et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infec Dis 2001;184:817-26.
4. Klinge J, Lugauer S, Korn K, Heininger U, Stehr K. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age. Vaccine 2000;18:3134-40.
5. Office fédéral de la santé publique. Vaccination contre les pneumocoques chez les enfants de moins de 5 ans: compléments aux recommandations parues en 2001. Bull 2003;N° 35:599-601.
6. www.bag.admin.ch/infekt/publ/wissenschaft/d/hepb_poster.pdf
7. Vaccination contre la varicelle. Recommandations de la Commission suisse pour les vaccinations et de l'Office fédéral de la santé publique. Bulletin 45/04 (1.11.2004), Office fédéral de la santé publique, 846-8.
8. http://www.swissmedic.ch/fr/fach/overall.asp? theme=0.00085. 00003&theme_id=939
9. Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S: Canadian Paediatric Society/Health Canada Immunization Monitoring Program-Active (IMPACT). Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: A report from IMPACT. Pediatrics 2003;112:e348.
10. Bohlke K, Davis RL, Marcy SM, et al. Vaccine Safety Datalink Team. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003;112:815-20.
11. Jefferson T, Rudin M, Di Retrantonj C. Adverse events after immunisation with aluminium-containing DTP vaccines: Systematic review of the evidence. Lancet Infect Dis 2004;4:84-90.
12. http:/agmed.sante.gouv.fr/htm/10/myofasci/aviscs.pdf
13. http://books.nap.edu/catalog/10997.hml
14. Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 2004;63:838-42.
15. http://www.who.int/vaccine_safety/en/
16. http://www.cdc.gov/ncidod/diseases/hepatitis/b/hbv_ms.pdf